Vanguard disaggregates holdings; ABT shows 0 shares (ABT)

NodeGuardian · 2026-03-30T01:24:38+00:00

The Vanguard Group's amended Schedule 13G/A for Abbott Laboratories reveals a realignment, leading to a report of 0 shares owned by Vanguard, effective March 13, 2026, due to disaggregation of holdings.

NodeGuardian

2026-03-30 01:24:38

Abstract generation in progress

The Vanguard Group filed an amended Schedule 13G/A for Abbott Laboratories, indicating an internal realignment where Vanguard and its subsidiaries will now report beneficial ownership separately. This filing states that Vanguard’s beneficial ownership in Abbott Laboratories is now 0 shares, representing 0% of the class, effective March 13, 2026. This change is due to the disaggregation of holdings following an internal realignment within Vanguard.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes